Netherlands-based supplier of speciality coatings for flexible materials Stahl has finalised the integration of Weilburger Graphics’ packaging coatings business in Turkey. The transfer of the business took effect on 1 December 2025, and follows Stahl’s acquisition of Weilburger Graphics in 2024. The consolidation is intended to reinforce its position in Turkey’s packaging coatings segment. The Weilburger Graphics operations in Turkey now trade as Stahl Kimya. Stahl Kimya will provide a broader portfoli ...

(all amounts are in U.S. dollars except where otherwise indicated) MONTREAL, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Gildan Activewear Inc. (GIL: TSX and NYSE) (“Gildan” or the “Company”) announced today that it has completed the previously announced acquisition of HanesBrands Inc. (“HanesBrands”), creating a global apparel leader. “Today marks the beginning of an exciting new chapter. By welcoming HanesBrands into the Gildan family, we are doubling our scale, combining iconic brands with our world-class, low-cos ...

Core Insights - Bragar Eagel & Squire, P.C. is investigating officers and directors of Driven Brands Holdings, Inc. and Jasper Therapeutics, Inc. on behalf of long-term stockholders due to class action complaints filed against both companies [1][4] Driven Brands Holdings, Inc. (NASDAQ: DRVN) - A class action complaint was filed against Driven Brands on December 22, 2023, alleging that the company made materially false and misleading statements regarding its ability to integrate acquired businesses and the performance of its car wash segment [2][3] - The complaint claims that Driven Brands misrepresented its integration capabilities as a "core strength" and assured investors of "significant progress" in integrating its U.S. auto glass businesses, while downplaying issues related to customer demand in its car wash segment [3] Jasper Therapeutics, Inc. (NASDAQ: JSPR) - A class action complaint was filed against Jasper Therapeutics on September 19, 2025, alleging that the company made materially false and misleading statements about its business operations and compliance policies [4][5] - The complaint highlights that Jasper lacked necessary controls to ensure third-party manufacturers complied with cGMP regulations, which increased risks for ongoing studies and overstated the company's financial and clinical prospects [5]

Core Insights - Saks Global has undergone a significant management reorganization aimed at cost reduction and enhancing relationships with brands and vendors, with CEO Marc Metrick taking a more direct role in brand partnerships [1][5][6] - Key executives, including Emily Essner and Bill Bine, have left the company, while Kim Miller has been appointed as the new chief customer officer [2][3][6] - The company reported a revenue decline of 11.1% in Q2, totaling $1.6 billion, attributed to inventory issues and increased costs, but expressed optimism for the upcoming holiday season [8][9] Management Changes - Emily Essner, previously president and chief commercial officer, has departed after overseeing critical strategies for 14 years [6] - Bill Bine, chief transformation officer, and Rob Brooks, chief operating officer, have also left, with their responsibilities reassigned to existing executives [2][3] - Kim Miller has been promoted to chief customer officer, focusing on customer satisfaction and retention across Saks Global [5][6] Brand Partnerships and Strategy - Paolo Riva will report directly to Marc Metrick, enhancing the focus on brand partner strategies [3][5] - Metrick aims to strengthen relationships with brand partners to maximize growth potential across Saks Global's luxury retail brands [5][6] Financial Performance - Saks Global's Q2 revenues fell to $1.6 billion from $1.8 billion, with a net loss of $288 million compared to $271 million the previous year [8] - The company is on track to achieve an annualized synergy target of $600 million, with $300 million in run-rate synergies already executed [9] Inventory and Vendor Relations - Saks Global is working to improve inventory flow and relationships with vendors, addressing issues related to late payments [10] - The company is exploring strategic options for Bergdorf Goodman, including the potential sale of a 49% minority stake, which could value the store between $1.5 billion and $2 billion [12]

Core Insights - Coty is conducting a strategic review of its consumer beauty segment to "unleash its full potential" focusing on its $1.2 billion mass colour cosmetics business and its Brazilian operations generating close to $400 million in revenue [1][2] Strategic Review - The review will explore various options including partnerships, divestitures, spin-offs, and other strategic actions to maximize long-term value and strengthen the balance sheet [2] - Coty plans to integrate its Prestige Beauty and Mass Fragrance businesses more closely, emphasizing its heritage and core strengths [2][3] Organizational Changes - The company aims to drive organizational changes for closer integration and coordination between prestige and consumer beauty fragrances, which currently account for 69% of Coty's sales [3] - The new structure will leverage Coty's scale in research and development, consumer insights, manufacturing, and distribution [3] Leadership and Management - CEO Sue Nabi highlighted that integrating fragrance brands will unlock the full potential of Coty's scale, as the fragrance category outperforms the global beauty market [4] - Gordon von Bretten has been appointed as president of consumer beauty, responsible for delivering the potential of mass cosmetics and personal care brands, and will lead the strategic review [5][6] Future Focus - The agenda includes realizing the full potential of market-leading brands by focusing the portfolio, enhancing product excellence, and driving productivity for visible growth, margin expansion, and cash generation [6] - Coty's prestige division will continue to expand its cosmetics and skincare offerings [4]

Financial Data and Key Metrics Changes - The company reported a revenue of $3,600,000,000, reflecting an 8.3% increase compared to the previous year [12][8] - Underlying EBITDA was $95,200,000, up $2,800,000 or about 3% year-on-year, driven by a $25,000,000 increase in gross margin dollars [12][13] - Net profit after tax was $31,200,000, with statutory results showing a net profit of $20,600,000 [8][12] Business Line Data and Key Metrics Changes - Revenue from Australia and New Zealand grew to $3,500,000,000, an increase of 8%, with gross margin rising to $277,900,000, up 5% [21] - The Asian market saw revenue increase from $84,200,000 to $101,000,000, a growth of 20%, with gross margin up by 30% to $46,100,000 [23][24] - Clinical manufacturing signed its first contract manufacturing agreement, indicating growth potential in that segment [22] Market Data and Key Metrics Changes - The Australian pharmacy market experienced solid growth, while hospital pharmacy remained flat [21] - The Asian market, particularly Thailand, showed exceptional growth in aesthetics, contributing significantly to revenue increases [24] - Challenges were noted in Korea due to a doctors' strike, and modest growth was observed in the Philippines due to declining contracts [25] Company Strategy and Development Direction - The company aims to continue its three-two-one strategy, focusing on integrating its businesses and expanding in Asia [27] - There is a strong emphasis on organic growth through investments in sales teams and new business opportunities in dental, robotics, and aesthetics [27][28] - The company is committed to operational efficiencies and simplifying its business structure while exploring merger and acquisition opportunities, particularly in Asia [28] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving $12,000,000 in synergies for FY '26, building on the $5,000,000 achieved in FY '25 [14][26] - The outlook for revenue and profit growth remains positive, with expectations for improved profitability as synergies are realized [29] - Management highlighted a focus on the competitive landscape in retail pharmacy and the need to adapt to market changes [33] Other Important Information - The company completed a refinancing with Scott Pak, resulting in a $400,000,000 financial covenant-free facility, which is expected to save $2,000,000 in interest annually [18][19] - The company is working towards achieving ISO certifications and GMP accreditation for its facilities [26] Q&A Session Summary Question: Outlook on revenue and profit for next year - Management indicated that revenue growth would be positive but not necessarily at the same rate as FY '25, suggesting single mid-digit growth rates [32] Question: Competitive landscape in retail pharmacy - Management noted that the competitive landscape has evolved, particularly due to recent mergers, and they hope to continue benefiting from trends in the market [33] Question: Clarification on integration costs in EBITDA - Integration costs were clarified to be excluded from the underlying EBITDA, allowing for a clearer view of operational performance [36] Question: M&A pipeline and net debt to EBITDA ratio - Management expressed willingness to increase net debt to pursue opportunities, particularly in Asia, while remaining focused on outcomes [37] Question: Details on recent acquisitions - The AHP Dental acquisition is expected to provide growth opportunities, although it may not contribute significantly to EBITDA initially [46][47] Question: Focus on growth opportunities in Asia - Management confirmed a strong focus on growth opportunities in Asia, with plans to update stakeholders before the AGM [50] Question: Future financing arrangements with Scott Pak - Management confirmed a commitment to maintaining low costs of funds and flexibility in financing arrangements, with a minimum term of two years for the current facility [57]

Core Insights - Cheetah Net Supply Chain Service Inc. reported a significant revenue increase of 278.9% year-over-year for Q2 2025, totaling $354,126, despite an operating loss of $780,849 [2][4] - The company experienced a net loss of $512,528 for Q2 2025, which is a 6.8% improvement compared to the same period in 2024 [2][9] - Management is focusing on integrating recently acquired companies to build a more resilient growth foundation amid trade policy pressures [3] Financial Performance - Revenue from logistics and warehousing services for Q2 2025 was $354,126, with $52,684 (14.9%) from Edward Transit Express Group and $301,442 (85.1%) from TW & EW Services [4] - The cost of revenue for Q2 2025 was $319,226, leading to a gross profit of $34,900 [6][28] - General and administrative expenses decreased by 6.9% to $805,305 in Q2 2025, primarily due to reduced legal and accounting fees [7] Interest Income and Losses - Interest income for Q2 2025 was $272,228, a substantial increase of 863.9% compared to $28,241 in Q2 2024 [8][9] - The net loss from continuing operations for the six months ended June 30, 2025, was $1,266,437, compared to a net loss of $1,016,370 for the same period in 2024 [18][29] Discontinued Operations - The parallel-import vehicle business generated revenue of $200,297 in Q2 2024, with only one vehicle sold during that quarter [10] - The net loss for discontinued operations was approximately $62,858 for Q2 2024 [11] Liquidity and Cash Flow - As of June 30, 2025, the company had current assets of $9.9 million and current liabilities of approximately $0.9 million [21] - The company reported a net cash flow of $1.3 million from operating activities during the six months ended June 30, 2025 [22][30]

Financial Data and Key Metrics Changes - Net sales increased by approximately 8.4% to $1,035 million from $954.7 million in Q2 2024 [10] - Gross profit increased by 11.1% to $254.3 million, with gross profit margins rising approximately 59 basis points to 24.6% [12] - GAAP net income was $21.2 million or $0.49 per diluted share, compared to $15.5 million or $0.37 per diluted share in Q2 2024 [13] - Adjusted EBITDA was $65.4 million for Q2 2025, up from $56.2 million in the prior year [14] Business Line Data and Key Metrics Changes - Specialty sales grew by 8.7% year-over-year, driven by unique customer growth of approximately 3.6% and placement growth of 8.7% [7] - Center of the Plate pounds were approximately 4% lower than the prior year, but excluding the impact of the Texas commodity protein program, growth was 5.8% [8][33] - Adjusted operating expenses increased by 9.3% year-over-year, representing 18.25% of net sales for Q2 2025 [13] Market Data and Key Metrics Changes - Net inflation was reported at 7.2%, with 5% inflation in the specialty category and 10.8% in the center of the plate category [11] - Excluding the impact of attrition from the commodity poultry program, net inflation in the center of the plate category was 4.1% [11] Company Strategy and Development Direction - The company is focused on integrating Hardee's operations in Texas with its legacy operations to drive top-line and bottom-line improvements [6] - The strategy includes shedding non-core programs to enhance distribution capacity and profitability [7][35] - The company aims to grow its business in Texas to over $500 million through cross-selling and expanding its customer base [70] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the resilience of their customer base and the ability to gain market share despite industry challenges [19][20] - The company raised its full-year guidance for 2025, estimating net sales between $4 billion and $4.06 billion [17] - Management noted that the second half of the year is expected to show typical seasonality, with a projected 6% revenue growth [66] Other Important Information - The company achieved the Great Place to Work certification for the fourth consecutive year, highlighting its focus on employee culture [6] - Total liquidity at the end of Q2 was $260.3 million, including $96.9 million in cash [14] Q&A Session Summary Question: Are there any pockets of weakness or elevated restaurant closures? - Management noted some choppiness but overall expressed satisfaction with market share gains and customer resilience [19] Question: Have you seen an uplift in business dining with return to office policies? - Management indicated a net positive impact on lunch business in major cities but noted a balance with local markets [21] Question: How is summer travel impacting demand? - Management observed a good July, suggesting a rebalancing of tourism and restaurant spending [28][30] Question: What is the expected impact of Hardee's planned attrition on reported case growth? - Management expects continued impacts from the attrition, particularly in high-volume, low-margin programs [35][39] Question: What is the outlook for inflation in the second half? - Management indicated moderate inflation expectations, with potential unforeseen impacts from tariffs [46] Question: Can you elaborate on gross margin performance? - Management acknowledged moving parts affecting gross margin but highlighted improvements from various operational initiatives [52] Question: What is the outlook for M&A activity? - Management remains opportunistic regarding M&A, with ongoing evaluations of potential tuck-in acquisitions [72][75] Question: Are the 2028 goals contributing to current results? - Management confirmed that several initiatives related to the 2028 goals are contributing positively to current performance [80]

Financial Data and Key Metrics Changes - Total group profit before tax in Q2 2025 was $2.7 billion, a 30% increase compared to the same period last year, with core businesses growing their combined pretax profits by 25% [19] - Group revenues increased by 4% to $11.5 billion, with an 8% increase across core franchises, while operating expenses decreased by 3% to $8.7 billion [20] - Reported EPS was $0.72, with a return on CET1 capital of 15.3% and a cost income ratio of 75.4% [20] Business Line Data and Key Metrics Changes - Global Wealth Management (GWM) pretax profit was $1.4 billion, up 24%, with revenue growth outpacing expenses by five percentage points [27] - Investment Bank delivered a profit before tax of $526 million, up 28%, with revenues increasing by 13% to $2.8 billion, driven by global markets [40] - Asset Management profit before tax was $216 million, down 5% year on year, but up 8% excluding a prior year gain [38] Market Data and Key Metrics Changes - Invested assets reached $6.6 trillion, with strong client activity across all regions [5] - In The Americas, GWM profit growth was 48%, while EMEA saw a 30% increase in profit before tax [28] - APAC profits grew by 12%, supported by sustained sales momentum across net new assets, mandates, and deposits [29] Company Strategy and Development Direction - The company aims to complete the integration of Credit Suisse by 2026, with significant progress made in migrating client accounts [9] - Continued investment in The Americas and leveraging its position as the number one wealth manager in APAC are key strategic focuses [11] - The company is committed to enhancing client service through investments in infrastructure and AI [11] Management's Comments on Operating Environment and Future Outlook - Management noted ongoing market uncertainties affecting client execution of strategic plans, but expressed optimism about capital deployment once macroeconomic conditions stabilize [8] - The company expects to maintain a CET1 capital ratio of around 15% and a cost income ratio of less than 70% by 2026 [17] - Management highlighted the importance of regulatory developments in Switzerland and their potential impact on the business model [12] Other Important Information - The company recorded a litigation reserve net release of $427 million related to Credit Suisse's legacy US cross-border business [20] - The CET1 capital ratio was 14.4%, with a strong capital position allowing for a double-digit increase in dividends and share buyback plans [10] - The company has reduced its non-core risk-weighted assets by over 80% since 2023, freeing up significant capital [46] Q&A Session Summary Question: Discussion on the remaining $8 billion accrual at UBS AG - Management indicated that the expectation is for the $8 billion accrual to be upstreamed, with a target equity double leverage ratio of around 100% by the end of the year [50][51] Question: Update on Wealth Management in the US and adviser incentives - Management confirmed progress in improving the pretax margin in Wealth Management, with a focus on technology investment and adviser retention strategies [51][52] Question: Clarification on output floor and RWAs - Management acknowledged ongoing efforts to mitigate the impact of the output floor on RWAs, emphasizing that it is too early to predict the outcomes [58] Question: Expectations regarding capital proposals and legislative clarity - Management stated that clarity on capital proposals is uncertain, and they will not engage in mitigation strategies until the final rules are known [62][70] Question: Client behavior in Asia and revenue softness - Management noted strong flows in Asia but acknowledged softer revenues, indicating a need to understand client behavior in the current environment [80]